+1,100.9%
MRNA vs CF
+262.5%
+838.5%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CF | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.1% | -3.6% | -3.4% |
| 7D | -12.1% | +4.8% | -16.9% | -11.9% |
| 30D | -1.3% | +4.7% | -6.0% | -0.9% |
| 3M | +250.9% | +7.4% | +243.5% | +253.0% |
| 6M | +343.0% | +0.6% | +342.4% | +345.6% |
| YTD | +657.4% | +64.1% | +593.3% | +657.2% |
| 1Y | +794.9% | +51.4% | +743.5% | +795.1% |
| 3Y | +218.1% | +67.8% | +150.3% | +216.8% |
| 5Y | -3.4% | +114.1% | -117.5% | -2.8% |
| All | +1,100.9% | +262.5% | +838.5% | +1,221.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CF.
Daily Out/Under-Performance
Portfolio return minus CF return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CF return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CF wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling